Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.
dc.contributor.author | Hegarty, Shane V. | |
dc.contributor.author | O'Keefe, Gerard W. | |
dc.contributor.author | Sullivan, Aideen M. | |
dc.contributor.funder | Irish Research Council | en |
dc.contributor.funder | Health Research Board | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.date.accessioned | 2017-02-13T15:34:24Z | |
dc.date.available | 2017-02-13T15:34:24Z | |
dc.date.issued | 2014-10 | |
dc.date.updated | 2017-02-13T15:17:43Z | |
dc.description.abstract | Neuroprotection and neuroregeneration are two of the most promising disease-modifying therapies for the incurable and widespread Parkinson’s disease. In Parkinson’s disease, progressive degeneration of nigrostriatal dopaminergic neurons causes debilitating motor symptoms. Neurotrophic factors play important regulatory roles in the development, survival and maintenance of specific neuronal populations. These factors have the potential to slow down, halt or reverse the loss of nigrostriatal dopaminergic neurons in Parkinson’s disease. Several neurotrophic factors have been investigated in this regard. This review article discusses the neurodevelopmental roles and therapeutic potential of three dopaminergic neurotrophic factors: glial cell line-derived neurotrophic factor, neurturin and growth/differentiation factor 5. | en |
dc.description.sponsorship | Irish Research Council (R13702 and R15897); Health Research Board of Ireland (HRA/2009/127); Science Foundation Ireland (10/RFP/NES27860) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Hegarty, S.V., O’Keeffe, G.W. and Sullivan, A. M. (2014) 'Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease', Neural Regeneration Research, 9(19), pp. 1708-1711. doi:10.4103/1673-5374.143410 | en |
dc.identifier.doi | 10.4103/1673-5374.143410 | |
dc.identifier.endpage | 1711 | en |
dc.identifier.issn | 1673-5374 | |
dc.identifier.issued | 19 | en |
dc.identifier.journaltitle | Neural Regeneration Research | en |
dc.identifier.startpage | 1708 | en |
dc.identifier.uri | https://hdl.handle.net/10468/3623 | |
dc.identifier.volume | 9 | en |
dc.language.iso | en | en |
dc.publisher | Medknow Publications | en |
dc.rights | © Neural Regeneration Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0/ | en |
dc.subject | Neuroprotection | en |
dc.subject | Neurotrophic factors | en |
dc.subject | Nervous system development; | en |
dc.subject | Nigrostriatal dopaminergic neurons | en |
dc.subject | Glial cell line-derived neurotrophic factor | en |
dc.subject | Neurturin | en |
dc.subject | Growth/differentiation factor 5 | en |
dc.subject | Parkinson's disease | en |
dc.title | Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease. | en |
dc.type | Article (peer-reviewed) | en |